15-Apr-2026
TipRanks (Thu, 16-Apr 5:45 AM ET)
TipRanks (Mon, 13-Apr 12:41 PM ET)
HCA Healthcare (HCA) Receives a Hold from Wells Fargo
TipRanks (Mon, 13-Apr 6:58 AM ET)
Business Wire (Wed, 1-Apr 8:30 AM ET)
HCA Healthcare, Inc. 1st Quarter 2026 Earnings Conference Call
Business Wire (Thu, 26-Mar 4:00 PM ET)
HCA Healthcare Named as One of the 2026 World's Most Ethical Companies by Ethisphere
Business Wire (Wed, 18-Mar 8:30 AM ET)
92 HCA Healthcare Hospitals Earn Healthgrades Patient Safety Excellence Award
Business Wire (Tue, 10-Mar 8:30 AM ET)
HCA Healthcare, Inc. to Present at March Conferences
Business Wire (Thu, 26-Feb 4:30 PM ET)
HCA Healthcare Named a World's Most Admired Company by Fortune for the 12th Consecutive Year
Business Wire (Thu, 26-Feb 8:30 AM ET)
HCA Healthcare Hospitals Named on America's 50 Best Hospitals List for 2026 by Healthgrades
Business Wire (Thu, 29-Jan 8:30 AM ET)
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
Hca Healthcare trades on the NYSE stock market under the symbol HCA.
As of April 15, 2026, HCA stock price declined to $488.58 with 860,543 million shares trading.
HCA has a beta of 0.43, meaning it tends to be less sensitive to market movements. HCA has a correlation of 0.06 to the broad based SPY ETF.
HCA has a market cap of $109.26 billion. This is considered a Large Cap stock.
Last quarter Hca Healthcare reported $20 billion in Revenue and $8.01 earnings per share. This fell short of revenue expectation by $-145 million and exceeded earnings estimates by $.59.
In the last 3 years, HCA traded as high as $556.52 and as low as $215.96.
The top ETF exchange traded funds that HCA belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
HCA has outperformed the market in the last year with a return of +46.5%, while the SPY ETF gained +31.6%. However, in the most recent history, HCA shares have underperformed the stock market with its stock returning +1.1% in the last 3 month period and +2.9% for the last 2 week period, while SPY has returned +1.4% and +6.8%, respectively.
HCA support price is $490.40 and resistance is $506.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCA shares will trade within this expected range on the day.